A randomized, double‐blind, placebo‐controlled, parallel‐group 12‐week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment
Genevieve Z. Steiner, Alan Bensoussan, E.R. Andrews-Marney, Mahmoud A. Al‐Dabbas et autres
Abstract INTRODUCTION This study primarily aimed to evaluate the efficacy and safety of SaiLuoTong (SLT) on cognition in mild cognitive impairment (MCI). METHODS Community‐dwelling people with MCI aged ≥60 years were randomly assigned to 180 mg/day SLT or placebo for 12 weeks. …
au, sg, cn (code pays fourni par la source)
7 citations
Alzheimer s & Dementia Translational Research & Clinical Interventions